Tag Archive | "human papillomavirus"

Nivolumab Demonstrated Survival Benefit, Good Tolerance in Refractory HNSCC

Tuesday, June 7, 2016

0 Comments

Source: www.asco.org Author: Tim Donald, ELS   In the phase III comparative CheckMate 141 trial, nivolumab demonstrated a “significant improval in survival” in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC), compared with therapy of the investigator’s choice, according to Robert L. Ferris, MD, PhD, FACS, of the University of Pittsburgh […]

Continue reading...

Heading back to the office following head and neck cancer

Sunday, June 5, 2016

0 Comments

Source: blogs.biomedcentral.com Author: Daniel Caley In Cancers of the Head & Neck launching today publishes the first study looking at disability and employment outcomes in patients with head and neck cancer related to the human papillomavirus (HPV). Dr Shrujal Baxi, Section Editor for survivorship and patient related outcomes and author of this study, explains more […]

Continue reading...

Anti-cancer jab piloted in gay men

Thursday, May 26, 2016

0 Comments

Source: www.bbc.com Author: James Gallagher, Health editor A vaccine to reduce the risk of cancer is to be offered to homosexual men in England in a pilot scheme starting in June. The jab protects against human papillomavirus, which increases the risk of oral, anal and penile cancers. It has been offered to school-age girls, to […]

Continue reading...

HPV vaccination rates for boys in Nova Scotia climbing, province says

Wednesday, May 4, 2016

0 Comments

Source: www.cbc.ca Author: Jon Tattrie, CBC News Nova Scotia has one of the best HPV vaccination rates in the country with boys getting the vaccine at the same rate as girls, the province’s chief public health officer says. In 2008, Nova Scotia started offering the vaccine to Grade 7 girls to protect against cancer. In […]

Continue reading...

Forgotten patients: New guidelines help those with head-and-neck cancers

Monday, April 11, 2016

0 Comments

Source: www.fredhutch.org Author: Diane Mapes and Sabrina Richards Stigma, isolation and medical complexity may keep patients from getting all the care they need; recommendations aim to change that. Like many cancer patients, Jennifer Giesel has side effects from treatment. There’s the neuropathy in her hands, a holdover from chemo. There’s jaw stiffness from her multiple […]

Continue reading...

Imaging, physical examination find most recurrences of HPV-positive oropharyngeal cancer

Wednesday, March 2, 2016

0 Comments

Source: www.oncologynurseadvisor.com Author: Kathy Boltz, PhD Posttreatment imaging at 3 months and physical examinations during the 6 months following treatment can detect most recurrences in patients treated with definitive radiation therapy for oropharyngeal cancer caused by human papillomavirus (HPV).1 This research was presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium. A dramatic increase […]

Continue reading...

NCCN Is ‘Vague,’ So Study Clarifies H&N Cancer Follow-up

Tuesday, February 23, 2016

0 Comments

Source: www.medscape.com Author: Nick Mulcahy   Clinical guidelines can sometimes be slow to respond to epidemiology. Take the case of oropharyngeal cancers that are associated with human papillomavirus (HPV) infection. They are increasingly common in the United States and, as several studies have demonstrated, have better survival than cancers of this type that are not […]

Continue reading...

Oral cancer less likely in women who have more sex; but not the same for men

Thursday, February 18, 2016

0 Comments

Source: www.parentherald.com Author: Diane Ting Having more sex partners reduces the chance of oral cancer for women. Unfortunately, men are more likely to become infected as the number of oral sex partners increases. A study suggests that women who have more vaginal sex partners appear to have a lower risk of oral human papillomavirus (HPV) […]

Continue reading...

HPV vaccination rates are low, especially in Kansas and Missouri, and cancer experts are alarmed

Thursday, February 18, 2016

0 Comments

Source: www.kansascity.com Author: Lisa Gutierrez The HPV vaccine is recommended for girls and boys starting at ages 11 to 12. But in state-by-state comparisons, children in Kansas and Missouri rank at or near the bottom of the list. John Amis The Associated Press   The University of Kansas Cancer Center recently joined nearly 70 other […]

Continue reading...

New research opens door to understanding human tonsil cancer



Tuesday, November 3, 2015

0 Comments

Source: medicalxpress.com Author: staff Researchers at Simon Fraser University and the BC Cancer Agency have developed a groundbreaking method to identify and separate stem cells that reside in the tonsils. Their research, which sheds new light on the fight against oral cancer, is published today in the journal Stem Cell Reports. While stem cells in […]

Continue reading...